Fast, accurate infection diagnostics.
Point of Care. In 60 minutes.

From Innotive, for everyone.

Front view of the InnovativeDX diagnostic device with a touchscreen interface displaying InnovativeDX logo, and a designated testing area below, designed for easy access and efficient diagnostics.Front view of the InnovativeDX diagnostic device with a touchscreen interface displaying InnovativeDX logo, and a designated testing area below, designed for easy access and efficient diagnostics.

Next-generation
healthcare diagnostics

Line drawing of the InnovativeDX diagnostic device.

No lab required

The results you need for effective treatment at the point-of-care.

Line drawing of a medical book with a cross symbol on the cover.

Fast and accurate

We offer gold-standard diagnostic results in minutes, not days.

Line drawing of a magnifying glass.

A savvy investment

Reduce cost and improve healthcare outcomes over time.

In action

How it works

Seize the science

Medical technology to save money, time and patients.

01

Big change in a small device

Together we can make huge health leaps with technology that makes fast and accurate point-of-care diagnostics possible.

02

Designed for safety

We comprehensively review our products with clinicians and patients, and our innovative technology is diligently compliant with safety standards and legislation.

03

Hard evidence and sound science

Our product development is born from cutting-edge research performed at the world-renowned universities of Liverpool and Manchester.

InnotiveDx has shown strong comparative data for its UTI assay against leading regulatory standards and laboratory-based methods.

100%

AST agreement with CLSI M07 agar dilution method [1]

N=391

samples tested against CLSI M07 [2]

97%

Bacterial ID accuracy compared to 3rd party laboratory system [3]
References
[1] CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. [2] Internal company data using only on-panel (UTI-causing) species, performed on laboratory assay. [3] Internal company data using only on-panel (UTI-causing) species, performed on laboratory assay

Ask us anything

Curious clinicians and interested investors - we’re looking forward to all your questions.

Contact us
References
[1] CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. CLSI standard M07. Wayne, PA: Clinical and Laboratory Standards Institute; 2018. [2] Internal company data using only on-panel (UTI-causing) species, performed using a benchtop laboratory assay. [3] Internal company data using only on-panel (UTI-causing) species, performed using a benchtop laboratory assay.